Société Tunisienne des Maladies Respiratoires et d'Allergologie STMRA - Study Commentary | Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster

Sté Tunisienne des Maladies Respiratoires et d'Allergologie

Cercle des Bureaux - Appartement B 5-3 . 1082 Centre urbain Nord Tunis

Study Commentary | Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster

Zouhair Souissi

10 mars 2021

Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster – The Lancet Original study and news release: 3-month interval between first and second dose of Oxford COVID-19 vaccine results in higher vaccine efficacy than 6-week interval

The post Study Commentary | Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster appeared first on Links Medicus.

Lu 688 fois